Publications

What does research teach us about several topics that are of importance for the ADHD-SUD linkage? For each of the topics listed in the submenu on this page, you will find important publications.

• Network analysis of DSM symptoms of substance use disorders and frequently co-occurring mental disorders in patients with substance use disorder who seek treatment., López-Toro, E., Wolf, C. J., González, R. A., van den Brink, W., Schellekens, A., Vélez-Pastrana, M. C., & AFP Working Collaborative Group., J Clin Med. 2022 May 19;11(10):2883. doi: 10.3390/jcm11102883
• Effect of past pharmacotherapy for attention-deficit/hyperactivity disorder on substance use disorder. , Coetzee, C., Schellekens, A. F., Truter, I., & Meyer, A. , Eur Addict Res. 2022 Nov 4;1-10. doi: 10.1159/000526386
• The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study., Brynte, C., Aeschlimann, M., Barta, C., Begeman, A. H. A., Bäcker, A., Crunelle, C. L., ... & Franck, J. , BMC Psychiatry. 2022 Sep 23;22(1):625. doi: 10.1186/s12888-022-04259-6
• Assessment of attention-deficit hyperactivity disorder in people with substance use disorder: Another case of what gets measured gets done, Jesse T Young, Mark A Bellgrove and Shalini Arunogir, Australian & New Zealand Journal of Psychiatry. April 2021.
• Alcohol use disorders and ADHD, Luderer, Mathias Ramos Quiroga, Josep Antoni Faraone, Stephen V Zhang James, Yanli Reif, Andreas, Neuroscience & Biobehavioral Reviews. September 2021.
• The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder, Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., … Wang, Y., Neurosci Biobehav Rev. 2021 Sep;128:789-818.
• Adolescents with concurrent ADHD and substance use disorder; international consensus., Spijkerman, R., Crunelle, C. L., Özgen, M. H., Begeman, A. H. A., Dom, G., van de Glind, G., ... & Hendriks, V. M. , Eur Addict Res. 2022 Nov 4;1-10. doi: 10.1159/000526386
• Interaction between behavioral inhibition and neural alcohol cue-reactivity in ADHD and alcohol use disorder, S Vollstädt-Klein, S Gerhardt, A Lee, A Strosche, G Sharafi, R Nuriyeva, J Seidt, O Hennig, B Alm, D Hermann, WH Sommer, F Kiefer, M Luderer & E Sobanski, Psychopharmacology. 2020;10.1007/s00213-020-05492-1
• Differential Diagnosis in Patients with Substance Use Disorder and/or Attention-Deficit/Hyperactivity Disorder Using Continuous Performance Test, Slobodin O, Blankers M, Kapitány-Fövény M, Kaye S, Berger I, Johnson B, Demetrovics Z, van den Brink W, van de Glind G, Eur Addict Res 2020;26:151–161
• Validity of the ADHD Module of the Mini International Neuropsychiatric Interview PLUS for Screening of Adult ADHD in Treatment Seeking Substance Use Disorder Patients: ADHD Screening With MINI-Plus, Raul Felipe Palma-Álvarez , Csaba Barta, Pieter Jan Carpentier, Susan Carruthers, Cleo L Crunelle, Zsolt Demetrovics, Geert Dom, Stephen V Faraone, Johan Franck, Brian Johnson, Máté Kapitány-Fövény, Sharlene Kaye, Maija Konstenius, Frieda Matthys, Franz Moggi, Merete Møller, Arnt Schellekens, Arvid Skutle, Geurt van de Glind, Katelijne van Emmerik-van Oortmerssen, Sofie Verspreet, Robert A Schoevers, Sara Wallhed, Frances R Levin, Lara Grau-López , Miguel Casas , Wim van den Brink, Josep Antoni Ramos-Quiroga, IASP Research Group, Rev Psiquiatr Salud Ment. 2020 Jun 16;S1888-9891(20)30038-0
• Often Overlooked and Ignored, but Do Not Underestimate Its Relevance: ADHD in Addiction – Addiction in ADHD, Schellekens A.F.A., van den Brink W., Kiefer F., Goudriaan A.E., Eur Addict Res 2020;26:169–172
• The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities, Van de Glind G, Brynte C, Skutle A, Kaye S, Konstenius M, Levin F, Mathys F, Demetrovics Z, Moggi F, Ramos-Quiroga JA, Schellekens A, Crunelle C, Dom G, van den Brink W, Franck J, Eur Addict Res 2020;26:173-178. doi: 10.1159/000508870
• Attention Deficit Hyperactivity Disorder in Prisoners: Increased Substance Use Disorder Severity and Psychiatric Comorbidity, Vélez-Pastrana M.C. · González R.A. · Ramos-Fernández A. · Ramírez Padilla R.R. · Levin F.R. · Albizu García C., Eur Addict Res (DOI:10.1159/000508829)
• Attention Deficit Hyperactivity Disorder Increases Nicotine Addiction Severity in Adults Seeking Treatment for Substance Use Disorders: The Role of Personality Disorders, Sánchez-García N.C. · González R.A. · Ramos-Quiroga J.A. · van den Brink W. · Luderer M. · Blankers M. · Grau-Lopez L. · Levin F.R. · Kaye S. · Demetrovics Z. · van de Glind G. · Schellekens A. · Vélez-Pastrana M.C. · and the ICASA group, Eur Addict Res (DOI:10.1159/000508545)
• Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders, Icick R. · Moggi F. · Slobodin O. · Dom G. · Mathys F. · van den Brink W. · Levin F.R. · Blankers M. · Kaye S. · Demetrovics Z. · van de Glind G. · Velez-Pastrana M.C. · Schellekens A.S.A. · ICASA-group, Eur Addict Res (DOI:10.1159/000508546)
• Onset and Severity of Early Disruptive Behavioral Disorders in Treatment-Seeking Substance Use Disorder Patients with and without Attention-Deficit/Hyperactivity Disorder, González R.A. · Vélez-Pastrana M. · Blankers M. · Bäcker A. · Konstenius M. · Holtmann M. · Levin F.R. · Noack M. · Kaye S. · Demetrovics Z. · van de Glind G. · van den Brink W. · Schellekens A. · ICASA Group, Eur Addict Res (DOI:10.1159/000508653)
• International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder, Özgen H. · Spijkerman R. · Noack M. · Holtmann M. · Schellekens A.S.A. · van de Glind G. · Banaschewski T. · Barta C. · Begeman A. · Casas M. · Crunelle C.L. · Daigre Blanco C. · Dalsgaard S. · Demetrovics Z. · den Boer J. · Dom G. · Eapen V. · Faraone S.V. · Franck J. · González R.A. · Grau-López L. · Groenman A.P. · Hemphälä M. · Icick R. · Johnson B. · Kaess M. · Kapitány-Fövény M. · Kasinathan J.G. · Kaye S.S. · Kiefer F. · Konstenius M. · Levin F.R. · Luderer M. · Martinotti G. · Matthys F.I.A. · Meszaros G. · Moggi F. · Munasur-Naidoo A.P. · Post M. · Rabinovitz S. · Ramos-Quiroga J.A. · Sala R. · Shafi A. · Slobodin O. · Staal W.G. · Thomasius R. · Truter I. · van Kernebeek M.W. · Velez-Pastrana M.C. · Vollstädt-Klein S. · Vorspan F. · Young J.T. · Yule A. · van den Brink W. · Hendriks V., Eur Addict Res (DOI:10.1159/000508385)
• Screened Attention Deficit/Hyperactivity Disorder as a Predictor of Substance Use Initiation and Escalation in Early Adulthood and the Role of Self-Reported Conduct Disorder and Sensation Seeking: A 5-Year Longitudinal Study with Young Adult Swiss Men, Moggi F. · Schorno D. · Soravia L.M. · Mohler-Kuo M. · Estévez-Lamorte N. · Studer J. · Gmel G., Eur Addict Res (DOI:10.1159/000508304)
• ADHD Is Associated with a Higher Risk for Traumatic Events, Self-Reported PTSD, and a Higher Severity of PTSD Symptoms in Alcohol-Dependent Patients, Luderer M. · Reinhard I. · Richter A. · Kiefer F. · Weber T., Eur Addict Res (DOI:10.1159/000508918)
• Use Motives of Patients with Amphetamine-Type Stimulants Use Disorder and Attention-Deficit/Hyperactivity Disorder, Thurn D. · Riedner A. · Wolstein J., Eur Addict Res (DOI:10.1159/000508871)
• Association between Adult Attention Deficit/Hyperactivity Disorder and Intravenous Misuse of Opioid and Benzodiazepine in Patients under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study, Lugoboni F. · Zamboni L. · Mantovani E. · Cibin M. · Tamburin S. · Gruppo InterSERT di Collaborazione Scientifica, Eur Addict Res (DOI:10.1159/000505207)
• Adult Attention-Deficit/Hyperactivity Disorder and Quality of Life in High-Dose Benzodiazepine and Related Z-Drug Users, Lugoboni F. · Bertoldi A. · Casari R. · Mantovani E. · Morbioli L. · Tamburin S., Eur Addict Res (DOI:10.1159/000507852)
• The Utility of the CPT in the Diagnosis of ADHD in Individuals with Substance Abuse: A Systematic Review, Slobodin O., Eur Addict Res (DOI:10.1159/000508041)
• Effects of Substance Misuse and Family History of Substance Use Disorder on Delay Discounting in Adolescents and Young Adults with Attention-Deficit/Hyperactivity Disorder, Paraskevopoulou M. · van Rooij D. · Schene A.H. · Scheres A.P.J. · Buitelaar J.K. · Schellekens A.F.A., Eur Addict Res (DOI:10.1159/000509147)
• Screening for adult attention-deficit/hyperactivity disorder in alcohol dependent patients: Underreporting of ADHD symptoms in self-report scales, Luderer M, Kaplan-Wickel N, Richter A, Reinhard I, Kiefer F, Weber T, Drug and Alcohol Dependence 195 (2019) 52–58
• [ADHD screening in alcohol dependent subjects : Psychometric characteristics of ADHD self-report scale and Wender Utah Rating Scale short form]. [Article in German], Luderer M, Kaplan-Wickel N, Sick C, Richter A, Reinhard I, Kiefer F, Weber T, Nervenarzt. 2019 Apr 11
• Mini Review: Socio-Cultural Influences on the Link Between ADHD and SUD, Ortal Slobodin and Cleo L. Crunelle, Front Public Health. 2019; 7:173
• [ADHD in adult patients with substance use disorders]. [Article in German], Luderer M, Kiefer F, Reif A, Moggi F, Nervenarzt. 2019 Sep;90(9):926-931
• Genetic liability to ADHD and substance use disorders in individuals with ADHD, Theresa Wimberley, Esben Agerbo, Henriette Thisted Horsdal, Cæcilie Ottosen, Isabell Brikell, Thomas Damm Als, Ditte Demontis, Anders D. Børglum, Merete Nordentoft, Ole Mors, Thomas Werge, David Hougaard, Jonas Bybjerg‐Grauholm, Marie Bækvad Hansen, Preben Bo Mortensen, Anita Thapar, Lucy Riglin, Kate Langley, Søren Dalsgaard, Addiction. 2019 Dec 5
• International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder, Crunelle CL, van den Brink W, Moggi F, Konstenius M, Franck J, Levin FR, van de Glind G, Demetrovics Z, Coetzee C, Luderer M, Schellekens A, ICASA consensus group, Matthys F, Eur Addict Res. 2018;24(1):43-51
• Causal Factors of Increased Smoking in ADHD: A Systematic Review, van Amsterdam J, van der Velde B, Schulte M, van den Brink W, Subst Use Misuse. 2018 Feb 23;53(3):432-445
• Prevalence Estimates of ADHD in a Sample of Inpatients With Alcohol Dependence, Luderer M, Sick C, Kaplan-Wickel N, Reinhard I, Richter A, Kiefer F, Weber T, J Atten Disord. 2018 Jan 1
• International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder, Crunelle CL, van den Brink W, Moggi F, Konstenius M, Franck J, Levin FR, van de Glind G, Demetrovics Z, Coetzee C, Luderer M, Schellekens A, ICASA consensus group, Matthys F, Eur Addict Res. 2018;24(1):43-51
• International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder, Crunelle CL, van den Brink W, Moggi F, Konstenius M, Franck J, Levin FR, van de Glind G, Demetrovics Z, Coetzee C, Luderer M, Schellekens A, ICASA consensus group, Matthys F, Eur Addict Res. 2018;24(1):43-51
• Genetics of attention deficit hyperactivity disorder, Faraone SV, Larsson H, Mol Psychiatry. 2018 Jun 11
• ADHD & Addiction: Prevalence, diagnostic assessment and treatment of ADHD in substance use disorder patients, Katelijne van Emmerik-van Oortmerssen
• Mental distress and ADHD symptoms among individuals in Opioid Maintenance Treatment, Kristine Abel
• Childhood Psychiatric Disorders as Risk Factor for Subsequent Substance Abuse: A Meta-Analysis, Groenman AP, Janssen TWP, Oosterlaan J, J Am Acad Child Adolesc Psychiatry. 2017 Jul;56(7):556-569
• Neuroimaging the neural correlates of increased risk for substance use disorders in attention-deficit/hyperactivity disorder - A systematic review, Adisetiyo V, Gray KM, Am J Addict. 2017 Mar;26(2):99-111
• ADHD Medication and Substance-Related Problems, Quinn PD, Chang Z, Hur K, Gibbons RD, Lahey BB, Rickert ME, Sjölander A, Lichtenstein P, Larsson H, D'Onofrio BM, Am J Psychiatry. 2017 Sep 1;174(9):877-885
• WHO World Mental Health Survey Collaborators. The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys, Fayyad J, Sampson NA, Hwang I, Adamowski T, Aguilar-Gaxiola S, Al-Hamzawi A, Andrade LH, Borges G, de Girolamo G, Florescu S, Gureje O, Haro JM, Hu C, Karam EG, Lee S, Navarro-Mateu F, O'Neill S, Pennell BE, Piazza M, Posada-Villa J, Ten Have M, Torres Y, Xavier M, Zaslavsky AM, Kessler RC, Atten Defic Hyperact Disord. 2017 Mar;9(1):47-65
• Attention Deficit Hyperactivity Disorder Symptoms are Common in Patients in Opioid Maintenance Treatment, Fiksdal Abel K, Ravndal E, Clausen T, Bramness JG, Eur Addict Res. 2017;23(6):298-305
• Screening for adult attention deficit/hyperactivity disorder in high‐dose benzodiazepine dependent patients, Tamburin S, Federico A, Morbioli L, et al, The American Journal on Addictions 2017
• Diagnosing ADHD during active substance use: Feasible or flawed?, van Emmerik-van Oortmerssen K, Vedel E, Kramer FJ, Koeter MW, Schoevers RA, van den Brink W, Drug Alcohol Depend. 2017 Nov 1;180:371-375
• Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell us?, Pieter-Jan Carpentier, Frances R Levin, Harv Rev Psychiatry. 2017 Mar-Apr; 25(2): 50–64
• A Comparison of Self-Reported Emotional Regulation Skills in Adults With Attention- Deficit/Hyperactivity Disorder and Borderline Personality, Cavelti, M, Corbisiero, S, Bitto, H, Moerstedt, B, Newark, P, Faschina, S, Chanen, A, Moggi, F, & Stieglitz, R.-D, (2017) Disorder. Journal of Attention Disorders
• Psychopathology and traffic violations in subjects who have lost their driving license, Valero S, Bosch R, Corominas M, Giannoni A, Barrau V, Ramos-Quiroga JA, Casas M, Compr Psychiatry. 2017 Jul;76:45
• Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders, Skoglund C, Brandt L, D'Onofrio B, Larsson H, Franck J, Eur Neuropsychopharmacol. 2017 Nov;27(11):1144-1152
• Good Clinical Practice in the recognition and treatment of ADHD in adults with substance use dependence. Guideline for clinical practice Update january 2016, Matthys F. Crunelle CL, Brussel: P. van Deun
• Good Clinical Practice in de diagnose en behandeling van ADHD bij volwassenen met verslaving. Aanbevelingen voor de klinische praktijk Update januari 2016, Matthys F. Crunelle CL, Brussel: P. van Deun
• Richtlijn: ADHD en middelengebruik bij adolescenten. Met werkboek en Handleiding voor professionals, V. Hendriks, R. Spijkerman et al, Amersfoort: Resultaten Scoren
• Childhood trauma exposure in substance use disorder patients with and without ADHD, Konstenius M, Leifman A, van Emmerik-van Oortmerssen K, van de Glind G, Franck J, Moggi F, Ramos-Quiroga JA, Levin FR, Carpentier PJ, Skutle A, Bu ET, Kaye S, Demetrovics Z, Barta C, Auriecomb M, Fatséas M, Johnson B, Faraone SV, Allsop S, Carruthers S, Schoevers RA, Verspreet S, Dom G, Koeter MW, van den Brink W, Addict Behav. 2016 Oct 24;65:118-124
• Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers, Kaye S, Ramos-Quiroga JA, van de Glind G, Levin FR, Faraone SV, Allsop S, Degenhardt L, Moggi F, Barta C, Konstenius M, Franck J, Skutle A, Bu ET, Koeter MW, Demetrovics Z, Kapitány-Fövény M, Schoevers RA, van Emmerik-van Oortmerssen K, Carpentier PJ, Dom G, Verspreet S, Crunelle CL, Young JT, Carruthers S, Cassar J, Fatséas M, Auriacombe M, Johnson B, Dunn M, Slobodin O, van den Brink W, J Atten Disord. (2016)
• Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow-up? A longitudinal study involving young Swiss men, Vogel T, Dom G, van de Glind G, Studer J, Gmel G, Strik W, Moggi F, Addiction. 2016 Oct;111(10):1867-78
• Cognition and impulsivity in adults with attention deficit hyperactivity disorder with and without cocaine and/or crack dependence, Miguel CS, Martins PA, Moleda N, Klein M, Chaim-Avancini T, Gobbo MA, Alves TM, Silva MA, Louzã MR, Drug Alcohol Depend. 2016 Mar 1;160:97-104
• Dopamine and serotonin genetic risk scores predicting substance and nicotine use in attention deficit/hyperactivity disorder, Groenman AP, Greven CU, van Donkelaar MM, Schellekens A, van Hulzen KJ, Rommelse N, Hartman CA, Hoekstra PJ, Luman M, Franke B, Faraone SV, Oosterlaan J, Buitelaar JK, Addict Biol. 2016 Jul;21(4):915-23
• Early exposure to stimulant medications and substance-related problems: The role of medical and nonmedical contexts, McCabe SE, Veliz P, Boyd CJ, Drug Alcohol Depend. 2016 Jun 1;163:55-63
• Probabilities of ADD/ADHD and Related Substance Use Among Canadian Adults, Connolly RD, Speed D, Hesson J, Journal of Attention Disorders 2016
• Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit/hyperactivity disorder and cocaine dependence, Notzon DP, Mariani JJ, Pavlicova M, Glass A, Mahony AL, Brooks DJ, Grabowski J, Levin FR, Am J Addict. 2016 Dec;25(8):666-672
• Attention Deficit/Hyperactivity Disorder symptoms, type of offending and recidivism in a prison population: The role of substance dependence, Román-Ithier, J. C, Gonzalez, R. A, Vélez-Pastrana, M. C, González-Tejera, G, & Albizu-Garcia, C, (2016). Criminal Behaviour and Mental Health, 27(5)
• Predictors of persistence of ADHD into adulthood: a systematic review of the literature and meta-analysis, Caye A, Spadini AV, Karam RG, et al, Eur Child Adolesc Psychiatry 2016: 1-9
• Burden and Expressed Emotion of Caregivers in Cases of Adult Substance Use Disorder with and Without Attention Deficit/Hyperactivity Disorder or Autism Spectrum Disorder, Kronenberg LM, Goossens PJ, van Busschbach JT, van Achterberg T, van den Brink W, Int J Ment Health Addict. 2016;14:49-63. Epub 2015 Jul 21
• Factors Associated With Adherence to Methylphenidate Treatment in Adult Patients With Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders, Skoglund C, Brandt L, Almqvist C, D’Onofrio BM, Konstenius M, Franck J, Larsson H, J Clin Psychopharmacol. 2016 Jun;36(3):222-8
• Early developmental, temperamental and educational problems in ‘substance use disorder’ patients with and without ADHD. Does ADHD make a difference? , Skutle, A, Hellandsjø Bu ET, Jellestad FK, van Emmerik-van Oortmerssen, K, Dom, G, Verspreet, S, Carpentier, PJ, Ramos-Quiroga, JA, Franck, J, Konstenius, M, Kaye, S, Demetrovics, Z, Barta C, Fatséas M, Auriacombe, M, Johnson B, Faraone, SV, Levin, FR, Allsopp, S, Carruthers, S, Schoevers, RA, Koete, MWJ, van den Brink W, Moggi F, Møller M, van de Glind G, Addictive Behaviors Reports 2 (2015) 13–18
• Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults. , Young JT, Carruthers S, Kaye S, Allsop S, Gilsenan J, Degenhardt L, van de Glind G, van den Brink W, Preen D, Drug Alcohol Rev. 2015 Mar 18
• The Role of Different Aspects of Impulsivity as Independent Risk Factors for Substance Use Disorders in Patients with ADHD: A Review. , Ortal S, van de Glind G, Johan F, Itai B, Nir Y, Iliyan I, van den Brink W, Curr Drug Abuse Rev. 2015;8(2):119-33
• Neurocognitive predictors of substance use disorders and nicotine dependence in ADHD probands, their unaffected siblings, and controls: a 4-year prospective follow-up, Groenman AP, Oosterlaan J, Greven CU, Vuijk PJ, Rommelse N, Franke B, Hartman CA, Hoekstra PJ, Sergeant J, Faraone SV, Buitelaar J, J Child Psychol Psychiatry. 2015 May;56(5):521-9
• Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study, Wapp M, van de Glind G, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Carpentier PJ, Ramos-Quiroga JA, Skutle A, Bu ET, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, Auriacombe M, Johnson B, Faraone SV, Levin FR, Allsop S, Carruthers S, Schoevers RA, Koeter MW, van den Brink W, Moggi F; IASP Research Group, Eur Addict Res. 2015;21(4):188-94
• Childhood ADHD symptoms are associated with lifetime and current illicit substance-use disorders and in-site health risk behaviors in a representative sample of Latino prison inmates, González, R. A, Vélez-Pastrana, M. C, Ruiz Varcárcel, J. J, Levin, F. R, & Albizu-García, C. E, Journal of Attention Disorders, 2015; 19 (4), 301–312
• An Epidemiological Study of ADHD, Substance Use, and Comorbid Problems in Incarcerated Women in Sweden, Konstenius M, Larsson H, Lundholm L, Philips B, van de Glind G, Jayaram-Lindström N, Franck J, J Atten Disord. 2015 Jan;19(1):44-52
• Criteria and Concurrent Validity of Adult ADHD Section of the Psychiatry Research Interview for Substance and Mental Disorders, Ramos-Quiroga JA, Díaz-Digon L, Comín M, Bosch R, Palomar G, Chalita JP, Roncero C, Nogueira M, Torrens M, Casas M, J Atten Disord. 2015 Dec;19(12):999-1006
• Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial, Levin FR, Mariani JJ, Specker S, Mooney M, Mahony A, Brooks DJ, Babb D, Bai Y, Eberly LE, Nunes EV, Grabowski J, JAMA Psychiatry. 2015 Jun;72(6):593-602
• Personal recovery in individuals diagnosed with substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD), Kronenberg LM, Verkerk-Tamminga R, Goossens PJ, van den Brink W, van Achterberg T, Arch Psychiatr Nurs. 2015 Aug;29(4):242-8
• Integrated cognitive behavioral therapy for patients with substance use disorder and comorbid ADHD: two case presentations, van Emmerik-van Oortmerssen K, Vedel E, van den Brink W, Schoevers RA, Addict Behav. 2015 Jun;45:214-7
• Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD), Kronenberg LM, Goossens PJ, van Etten DM, van Achterberg T, van den Brink W, Perspect Psychiatr Care. 2015 Jan;51(1):4-15
• Coping styles in substance use disorder (SUD) patients with and without co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD), Kronenberg LM, Goossens PJ, van Busschbach J, van Achterberg T, van den Brink W, BMC Psychiatry. 2015 Jul 14;15:159
• Stimulant ADHD medication and risk for substance abuse, Zheng Chang, Paul Lichtenstein, Linda Halldner, Brian D’Onofrio, Eva Serlachius, Seena Fazel, Niklas Långström, and Henrik Larsson, J Child Psychol Psychiatry. 2014 Aug; 55(8): 878–885
• Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research, Molina BS, Pelham WE, Jr. Annu Rev Clin Psychol. 2014;10:607-39
• Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms, Kaye S, Gilsenan J, Young JT, Carruthers S, Allsop S, Degenhardt L, van de Glind G, van den Brink W, Drug Alcohol Depend. 2014 Nov 1;144:70-7
• Genetic and environmental influences on the relationship between adult ADHD symptoms and self-reported problem drinking in 6024 Dutch twins, Derks EM, Vink JM, Willemsen G, van den Brink W, Boomsma DI, Psychol Med. 2014. Sep;44(12):2673-83
• Genetic and environmental influences on the relationship between adult ADHD symptoms and self-reported problem drinking in 6024 Dutch twins, Derks EM, Vink JM, Willemsen G, van den Brink W, Boomsma DI, Psychol Med. 2014 Sep;44(12):2673-83
• Early-age clinical and developmental features associated to Substance Use Disorders in Attention-Deficit/Hyperactivity Disorder in Adults, Nogueira M, Bosch R, Valero S, Gómez-Barros N, Palomar G, Richarte V, Corrales M, Nasillo V, Vidal R, Casas M, Ramos-Quiroga JA, Compr Psychiatry. 2014 Apr;55(3):639-49
• Dopamine transporter occupancy by methylphenidate and impulsivity in adult ADHD, Crunelle CL, van den Brink W, Dom G, Booij J, Br J Psychiatry. 2014 Jun;204(6):486-7
• Stimulant ADHD medication and risk for substance abuse, Chang Z, Lichtenstein P, Halldner L, D'Onofrio B, Serlachius E, Fazel S, Långström N, Larsson H, J Child Psychol Psychiatry. 2014 Aug;55(8):878-85
• Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study, Katelijne van Emmerik-van Oortmerssen, Geurt van de Glind, Maarten W. J. Koeter, Steve Allsop, Marc Auriacombe, Csaba Barta, Eli Torild H. Bu, Yuliya Burren, Pieter-Jan Carpentier, Susan Carruthers, Miguel Casas, Zsolt Demetrovics, Geert Dom, Stephen V. Faraone, Melina Fatseas, Johan Franck, Brian Johnson, Máté Kapitány-Fövény, Sharlene Kaye, Maija Konstenius, Frances R. Levin, Franz Moggi, Merete Møller, J. Antoni Ramos-Quiroga, Arild Schillinger, Arvid Skutle, Wim van den Brink, Addiction. 2014 Feb;109(2):262-72
• Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. , Geurt van de Glind, Maija Konstenius, Maarten WJ Koeter, Katelijne van Emmerik-van Oortmerssen, Pieter-Jan Carpentier, Sharlene Kaye, Louisa Degenhardt, Arvid Skutle, Johan Franck, Eli-Torild Bu, Franz Moggi, Geert Dom, Sofie Verspreet, Zsolt Demetrovics, Máté Kapitány-Fövényk, Melina Fatséas, Marc Auriacombe, Arild Schillinger, Merete Møller, Brian Johnson, Stephen V. Faraone, J. Antoni Ramos-Quiroga, Miguel Casas, Steve Allsop, Susan Carruthers, Robert A. Schoevers, Sara Wallhed, Csaba Barta, Peter Alleman, Frances R. Levin, Wim van den Brink, and IASP Research Group, Drug Alcohol Depend. 2014 Jan 1;134:158-66
• «Se meg, i tide»: ADHD som tidlig risikofaktor for rusmiddelmisbruk – en sammenlignende studie. ADHD as an early risk factor for substance use disorder a comparative study, Arvid Skutle, Eli Torild Hellandsj ø Bu, Finn Konow Jellestad, Geurt van de Glind, Tidsskrift for Norsk Psykologforening. Vol 51, nummer 4, 2014, side 286-292
• Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial, Konstenius M, Jayaram-Lindström N, Guterstam J, Beck O, Philips B, Franck J, Addiction. 2014 Mar;109(3):440-9
• Barriers to implementation of treatment guidelines for ADHD in adults with substance use disorder, Matthys F, Soyez V, van den Brink W, Joostens P, Tremmery S, Sabbe B, J Dual Diagn. 2014;10(3):130-8
• Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient's perspective, Kronenberg LM, Slager-Visscher K, Goossens PJ, van den Brink W, van Achterberg T, BMC Psychiatry. 2014 Sep 19;14:264
• [Prevalence of attention deficit/hyperactivity disorder symptoms in outpatient adolescents and young adults with other psychiatric disorders refractory to previous treatments]. [Article in Spanish], Vidal R, Barrau V, Casas M, Caballero-Correa M, Martínez-Jiménez P, Ramos-Quiroga JA, Rev Psiquiatr Salud Ment. 2014 Jul-Sep;7(3):104-12
• Stimulant Medication for ADHD in Opioid Maintenance Treatment, Abel KF, Martinsen E, Bramness JG, J Dual Diagn. 2014;10:1, 32-38
• Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study, Groenman AP, Oosterlaan J, Rommelse N, Franke B, Roeyers H, Oades RD, Sergeant JA, Buitelaar JK, Faraone SV, Addiction. 2013 Aug;108(8):1503-11
• Impulsivity in adult ADHD patients with and without cocaine dependence, Crunelle CL, Veltman DJ, van Emmerik-van Oortmerssen K, Booij J, van den Brink W, Drug Alcohol Depend. 2013 Apr 1;129(1-2):18-22
• Association between craving and Attention Deficit/Hyperactivity Disorder (ADHD) symptoms among patients with Alcohol Use Disorders, Seitz, A, Wapp, W, Burren, Y, Stutz, S, Schläfli, S. & Moggi, F, The American Journal on Addictions, 22, 292-296
• Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs), Sánchez-Mora C, Ramos-Quiroga JA, Garcia-Martínez I, Fernàndez-Castillo N, Bosch R, Richarte V, Palomar G, Nogueira M, Corrales M, Daigre C, Martínez-Luna N, Grau-Lopez L, Toma C, Cormand B, Roncero C, Casas M, Ribasés M, Eur Neuropsychopharmacol. 2013 Nov;23(11):1463-73
• Associations between attention deficit hyperactivity disorder symptom domains and DSM- IV lifetime substance dependence, Ameringer, K, J, Leventhal, AM, American journal of addiction. 22 (1): 23-32
• Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder, Groenman AP, Oosterlaan J, Rommelse NN, Franke B, Greven CU, Hoekstra PJ, Hartman CA, Luman M, Roeyers H, Oades RD, Sergeant JA, Buitelaar JK, Faraone SV, Br J Psychiatry. 2013 Aug;203(2):112-9
• Stimulant medication and substance use outcomes: a meta-analysis, Humphreys KL, Eng T, Lee SS, JAMA Psychiatry. 2013 Jul;70(7):740-9
• ADHD in treatment seeking patients with a substance use disorder. PhD thesis Summary and complete study, Geurt van de Glind
• The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population. , van de Glind G, Van Emmerik-van Oortmerssen K, Carpentier PJ, Levin FR, Koeter MW, Barta C, Kaye S, Skutle A, Franck J, Konstenius M, Bu ET, Moggi F, Dom G, Demetrovics Z, Fatséas M, Schillinger A, Kapitány-Fövény M, Verspreet S, Seitz A, Johnson B, Faraone SV, Ramos-Quiroga JA, Allsop S, Carruthers S, Schoevers RA; Iasp Research Group, van den Brink W, Int J Methods Psychiatr Res. 2013, 22(3): 232–244
• Attention deficit hyperactivity disorder in cocaine-dependent adults: a psychiatric comorbidity analysis, Daigre C, Roncero C, Grau-López L, Martínez-Luna N, Prat G, Valero S, Tejedor R, Ramos-Quiroga JA, Casas M, Am J Addict. 2013 Sep-Oct;22(5):466-73
• Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients, van de Glind G, van den Brink W, Koeter MW, Carpentier PJ, van Emmerik-van Oortmerssen K, Kaye S, Skutle A, Bu ET, Franck J, Konstenius M, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, Fatséas M, Auriacombe M, Schillinger A, Seitz A, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Barta C, Schoevers RA; IASP Research Group, Levin FR, Drug Alcohol Depend. 2013 Oct 1;132(3):587-96
• Long-term relationship between methylphenidate and tobacco consumption and nicotine craving in adults with ADHD in a prospective cohort study, Bron TI, Bijlenga D, Kasander MV, Spuijbroek AT, Beekman AT, Kooij JJ, Eur Neuropsychopharmacol. 2013 Jun;23(6):542-54
• Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial, van Emmerik-van Oortmerssen K, Vedel E, Koeter MW, de Bruijn K, Dekker JJ, van den Brink W, Schoevers RA, BMC Psychiatry. 2013 May 10;13:132
• Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence, Crunelle CL, van den Brink W, Veltman DJ, van Emmerik-van Oortmerssen K, Dom G, Schoevers RA, Booij J, Eur Neuropsychopharmacol. 2013 Dec;23(12):1714-23
• Reduced striatal brain volumes in non-medicated adult ADHD patients with comorbid cocaine dependence, van Wingen GA, van den Brink W, Veltman DJ, Schmaal L, Dom G, Booij J, Crunelle CL, Drug Alcohol Depend. 2013 Aug 1;131(3):198-203
• Verslaving en ADHD: Een overzicht van recent Nederlands onderzoek, van Emmerik-van Oortmerssen K, Crunelle CL, Carpentier PJ, Tijdschr Psychiatr. 2013; 55(11):861-6
• ADHD in Substance Use Disorders: Prevalence and Pharmacotherapy, Maija Konstenius
• The role of conduct disorder in the association between ADHD and alcohol use (disorder). Results from the Netherlands Mental Health Survey and Incidence Study-2, Tuithof M, ten Have M, van den Brink W, Vollebergh W, de Graaf R, Drug Alcohol Depend. 2012 Jun 1;123(1-3):115-21
• Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. , van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, Smit F, Crunelle CL, Swets M, Schoevers RA, Drug Alcohol Depend. 2012 Apr 1;122(1-2):11-9
• Validering av ADHD-screeninginstrumentet ASRS-v1.1 for pasienter i behandling for rusmiddelavhengighet, Eli Torild Hellandsjø Bu, Arvid Skutle, Therese Dahl, Eva Løvaas & Geurt van de Glind, Tidsskrift for Norsk psykologforening, Vol 49, nummer 11, 2012, side 1067-1073
• Addiction and the role of childhood externalising disorders, Pieter-Jan Carpentier
• Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review, Lee SS, Humphreys KL, Flory K, Liu R, Glass K, Clin Psychol Rev. 2011 Apr;31(3):328-41
• Childhood attention deficit/ hyperactivity disorder and future substance use disorders: comparative meta- analyses, Charach, A, Yeung, E, Climans, T, Lillie, E, Journal of the academy of American child and adolescent child psychiatry. 2011 50: 9-21
• Forekomst av AD/HD blant pasienter i behandling for rusmiddelavhengighet, Arvid Skutle, Eli Torild Hellandsjø Bu, Therese Dahl, Eva Karin Løvaas, Arild Schillinger, Merete Møller & Geurt van de Glind, Tidsskrift for Norsk psykologforening, Vol 48, nummer 9, 2011, side 863-868
• Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders, Riggs PD, Winhusen T, Davies RD, Leimberger JD, Mikulich-Gilbertson S, Klein C, Macdonald M, Lohman M, Bailey GL, Haynes L, Jaffee WB, Haminton N, Hodgkins C, Whitmore E, Trello-Rishel K, Tamm L, Acosta MC, Royer-Malvestuto C, Subramaniam G, Fishman M, Holmes BW, Kaye ME, Vargo MA, Woody GE, Nunes EV, Liu D, J Am Acad Child Adolesc Psychiatry 2011;50:903–914
• Do candidate genes discriminate patients with an autism spectrum disorder from those with attention deficit/hyperactivity disorder and is there an effect of lifetime substance use disorders?, Sizoo B, van den Brink W, Franke B, Vasquez AA, van Wijngaarden-Cremers P, van der Gaag RJ, World J Biol Psychiatry. 2010 Aug;11(5):699-708
• Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability. , Sizoo B, van den Brink W, Koeter M, Gorissen van Eenige M, van Wijngaarden-Cremers P, van der Gaag RJ, Drug Alcohol Depend. 2010 Feb 1;107(1):44-50
• Using the Autism-spectrum quotient to discriminate Autism Spectrum Disorder from ADHD in adult patients with and without comorbid Substance Use Disorder, Sizoo BB, van den Brink W, Gorissen-van Eenige M, Koeter MW, van Wijngaarden-Cremers PJ, van der Gaag RJ, J Autism Dev Disord. 2009 Sep;39(9):1291-7
• Adult ADHD Self-Report Scale (ASRS-v1.1) symptom checklist in patients with substance use disorders, Daigre Blanco C, Ramos-Quiroga JA, Valero S, Bosch R, Roncero C, Gonzalvo B, Nogueira M, Actas Esp Psiquiatr. 2009 Nov-Dec;37(6):299-305
• Personality characteristics of adults with autism spectrum disorders or attention deficit hyperactivity disorder with and without substance use disorders, Sizoo B, van den Brink W, Gorissen van Eenige M, van der Gaag RJ, J Nerv Ment Dis. 2009 Jun;197(6):450-4
• Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders, Wilens TE, Adler LA, Weiss MD, Michelson D, Ramsey JL, Moore RJ, Renard D, Brady KT, Trzepacz PT, Schuh LM, Ahrbecker LM, Levine LR. Atomoxetine ADHD/SUD Study Group, Drug Alcohol Depend. 2008 Jul 1;96(1-2):145-54
• Prospective effects of attention-deficit/ hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse, Elkins IJ, McGue M, Iacono WG, Arch Gen Psychiatry. 2007 Oct;64(10):1145-52